bluebird bio Inc
NASDAQ:BLUE

Watchlist Manager
bluebird bio Inc Logo
bluebird bio Inc
NASDAQ:BLUE
Watchlist
Price: 4.97 USD Market Closed
Market Cap: 48.7m USD

Wall Street
Price Targets

BLUE Price Targets Summary
bluebird bio Inc

There are no price targets for BLUE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
bluebird bio Inc Competitors:
Price Targets
CNTB
Connect Biopharma Holdings Ltd
255% Upside
2157
Lepu Biopharma Co Ltd
95% Upside
PGEN
Precigen Inc
101% Upside
ALKS
Alkermes Plc
57% Upside
4BB
4Basebio PLC
167% Upside
CELC
Celcuity Inc
7% Upside
301047
Sino Biological Inc
19% Upside
FOLD
Amicus Therapeutics Inc
18% Upside

Revenue
Forecast

Revenue Estimate
bluebird bio Inc

For the last 12 years the compound annual growth rate for bluebird bio Inc's revenue is 58%. The projected CAGR for the next 3 years is 46%.

58%
Past Growth
46%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
bluebird bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
bluebird bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BLUE's stock price target?
Not Available

BLUE doesn't have any price targets made by Wall Street professionals.

What is bluebird bio Inc's Revenue forecast?
Projected CAGR
46%

For the last 12 years the compound annual growth rate for bluebird bio Inc's revenue is 58%. The projected CAGR for the next 3 years is 46%.

Back to Top